Relypsa to Present at Two Upcoming Conferences
September 02, 2015 08:30 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., Sept. 2, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP) today announced that the company will present at two upcoming investor conferences in September 2015.
Kristine...
Relypsa Announces New Employment Inducement Grants
August 18, 2015 16:30 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., Aug. 18, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on August 17, 2015, the compensation committee of the company's...
Relypsa Enters Two-Year Detailing Agreement With Sanofi in the United States
August 10, 2015 16:06 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., Aug. 10, 2015 (GLOBE NEWSWIRE) -- Relypsa Inc. (NASDAQ:RLYP), a biopharmaceutical company, today announced it has entered a two-year detailing agreement with Sanofi for Patiromer...
Relypsa and Vifor Fresenius Medical Care Renal Pharma Enter Into Partnership to Commercialize Patiromer FOS in Europe and Additional Territories
August 10, 2015 16:05 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., and ST. GALLEN, Switzerland, Aug. 10, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (NASDAQ:RLYP), a biopharmaceutical company, and Vifor Fresenius Medical Care Renal Pharma Ltd....
Relypsa Announces Second Quarter 2015 Financial Results
August 06, 2015 16:15 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (NASDAQ:RLYP), a biopharmaceutical company, today reported financial results for the quarter ended June 30, 2015. Net loss for the...
Relypsa Announces New Employment Inducement Grants
August 05, 2015 08:30 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., Aug. 5, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on August 3, 2015, the compensation committee of the company's...
Relypsa Announces New Employment Inducement Grants
July 24, 2015 08:30 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., July 24, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on July 15, 2015, the compensation committee of the company's...
JAMA Publishes Long-Term Safety and Efficacy Results of Trial With Relypsa's Patiromer FOS Over One Year
July 14, 2015 11:48 ET
|
Relypsa, Inc.
Patiromer FOS significantly decreased blood potassium levels in patients with chronic kidney disease and hyperkalemia at four weeks (primary endpoint)
Potassium levels were maintained at...
Relypsa Announces New Employment Inducement Grants
July 02, 2015 08:30 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., July 2, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on July 1, 2015, the compensation committee of the company's board...